Haleon’s rumored interest in acquiring Sanofi’s Consumer Healthcare business has been met with surprise and skepticism by analysts.
A 31 January Bloomberg article claimed Haleon was weighing up large potential deals for the medium- to long-term, with Sanofi CHC a potential target
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?